262 related articles for article (PubMed ID: 24443913)
21. Comparison between familial and nonfamilial melanoma in France.
Grange F; Chompret A; Guilloud-Bataille M; Guillaume JC; Margulis A; Prade M; Demenais F; Avril MF
Arch Dermatol; 1995 Oct; 131(10):1154-9. PubMed ID: 7574832
[TBL] [Abstract][Full Text] [Related]
22. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
[TBL] [Abstract][Full Text] [Related]
23. Association between dietary fat and skin cancer in an Australian population using case-control and cohort study designs.
Granger RH; Blizzard L; Fryer JL; Dwyer T
BMC Cancer; 2006 May; 6():141. PubMed ID: 16734890
[TBL] [Abstract][Full Text] [Related]
24. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: the Women's Health Initiative Observational Study.
Rosenberg CA; Khandekar J; Greenland P; Rodabough RJ; McTiernan A
Cancer; 2006 Feb; 106(3):654-63. PubMed ID: 16365851
[TBL] [Abstract][Full Text] [Related]
26. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
[TBL] [Abstract][Full Text] [Related]
27. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales.
Giles G; Staples M; McCredie M; Coates M
Melanoma Res; 1995 Dec; 5(6):433-8. PubMed ID: 8589618
[TBL] [Abstract][Full Text] [Related]
28. Second nonmelanoma skin cancer in Spain: frequency and chronology.
Domínguez-Cruz JJ; Nieto-García A; Rios JJ; Moreno-Ramirez D
Br J Dermatol; 2014 Mar; 170(3):716-9. PubMed ID: 24124768
[TBL] [Abstract][Full Text] [Related]
29. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract][Full Text] [Related]
30. High constant incidence rates of second cutaneous melanomas.
Levi F; Randimbison L; Te VC; La Vecchia C
Int J Cancer; 2005 Dec; 117(5):877-9. PubMed ID: 15957164
[TBL] [Abstract][Full Text] [Related]
31. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
[TBL] [Abstract][Full Text] [Related]
32. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
33. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
34. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
[TBL] [Abstract][Full Text] [Related]
35. A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland.
Eldon BJ; Thorlacius S; Jonsson T; Jonasson JG; Kjartansson J; Bodvarsson S; Steingrimsson E; Rafnar T
Eur J Cancer; 2006 May; 42(7):922-6. PubMed ID: 16530404
[TBL] [Abstract][Full Text] [Related]
36. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
37. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
38. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
Brewster AM; Alberg AJ; Strickland PT; Hoffman SC; Helzlsouer K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1271-5. PubMed ID: 15298945
[TBL] [Abstract][Full Text] [Related]
39. Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.
Borghi A; Corazza M; Chiaranda G; Michiara M; Mangone L; Caruso B; Falcini F; Maestri I; Ferretti S
Cancer Epidemiol; 2019 Aug; 61():176-184. PubMed ID: 31301588
[TBL] [Abstract][Full Text] [Related]
40. Do perinatal and early life exposures influence the risk of malignant melanoma? A Northern Ireland birth cohort analysis.
O'Rorke MA; Black C; Murray LJ; Cardwell CR; Gavin AT; Cantwell MM
Eur J Cancer; 2013 Mar; 49(5):1109-16. PubMed ID: 23146960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]